Vaccination on Rheumatology Digesthttps://rheumatologydigest.org/tags/vaccination/Recent content in Vaccination on Rheumatology DigestHugoen-usMon, 25 May 2026 06:00:00 +0530Recombinant Zoster Vaccine in Inflammatory Rheumatic Disease — Efficacy, Long-Term Protection and Safety Under Immunosuppressionhttps://rheumatologydigest.org/posts/rzv-immunosuppression-review/Mon, 25 May 2026 06:00:00 +0530https://rheumatologydigest.org/posts/rzv-immunosuppression-review/A 2026 RMD Open narrative review of recombinant zoster vaccine (RZV) in inflammatory rheumatic disease — robust efficacy across IRD cohorts (~95% reduction in HZ recurrence; 54–70% effectiveness in SLE), no meaningful short-term flare signal in RCT data, and a practical drug-by-drug timing framework spanning csDMARDs, biologics, JAK inhibitors and B-cell depletion.